FDA sunscreen TFM proposed amendment on UVA testing methods, labeling upcoming.
This article was originally published in The Rose Sheet
Executive Summary
AVOBENZONE SUNSCREEN INTERIM MARKETING APPROVAL DUE END OF MARCH, FDA's John Lipnicki, an interdisciplinary scientist in the Division of OTC Drugs, said at a sunscreen OTC "feedback" meeting with the Cosmetic, Toiletry and Fragrance Association and the Nonprescription Drug Manufacturers Association Feb. 11 in Rockville, Md. While "an estimate...on the completion time" for the final rule on OTC sunscreens is not available, FDA plans on "making a determination as soon as possible on the interim marketing status of avobenzone," Lipnicki said.